Skip to main content

Table 3 Suicide deaths and rates over time by mood stabilizer treatment

From: Suicide risk in Veterans Health Administration patients with mental health diagnoses initiating lithium or valproate: a historical prospective cohort study

A. Primary Analysis (Intent-to-treat, 0–365 days)

 

All Patients Initiating Treatment (Intent-to-Treat Cohort)

  
 

Patients Initiating Lithium

Patients Initiating Valproate

  

Follow-up Time

Patients, No.

Suicide Deaths, No.

Rate (per 106 person-days)

Patients, No.

Suicide Deaths, No.

Rate (per 106 person-days)

Conditional Odds Ratio (95% CI)

Rate Ratio

0-365 days

21194

56

7.27

21194

46

5.98

1.22a (0.82-1.81)

1.22

B. Findings Stratified by Initial Treatment Status (0–365 days)

 

During Exposure to Initial Treatmentb

  
 

Patients Initiating Lithium

Patients Initiating Valproate

  

Follow-up Time

Patients, No.

Suicide Deaths, No.

Rate (per 106 person-days)

Patients, No.

Suicide Deaths, No.

Rate (per 106 person-days)

Conditional Odds Ratio (95% CI)

Rate Ratio

0-365 days

21194

18

6.71

21194

21

7.68

0.86c (0.46-1.61)

0.87

 

During Period After Stopping/Modifying Initial Treatmentd

  
 

Patients Initiating Lithium

Patients Initiating Valproate

  

Follow-up Time

Patients, No.

Suicide Deaths, No.

Rate (per 106 person-days)

Patients, No.

Suicide Deaths, No.

Rate (per 106 person-days)

Odds Ratio (95% CI)

Rate Ratio

0-365 days

19494

38

7.58

19362

25

5.05

1.51e (0.91-2.50)

1.50